Virtual Reality for the Improvement of Patients Understanding of Disease and Treatment (MRgRT)
NCT ID: NCT05600556
Last Updated: 2025-05-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2024-06-01
2025-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiac Effects From Radiation Therapy by MRI
NCT04486573
Magnetic Resonance Imaging Development for High Resolution Atrial Structural and Functional Characterization
NCT06617624
Transmyocardial Laser Revascularization and Cardiovascular Magnetic Resonance Imaging
NCT01287910
Calibration of MR and PET-MR Imaging Protocols at RIC
NCT02249520
Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Cardiac Transplant Rejection
NCT01136135
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. Examine patient reported comprehension of their tumor characteristics and treatment plan following 3D virtual reality review of their imaging.
SECONDARY OBJECTIVE:
I. Examine patient reported treatment related anxiety prior to and following virtual reality (VR) simulation of the MRI Linac treatment process.
OUTLINE: Patients are assigned to 1 of 2 cohorts.
COHORT I: Patients receive two-dimensional (2D) image review using standard computer screen on study. Patients undergo MRI and computed tomography (CT) imaging at screening and on study.
COHORT II: Patients receive image review using virtual reality stimulation on study. Patients also view MRI treatment room using virtual reality stimulation. Patients undergo MRI and CT imaging at screening and on study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort I (standard imaging)
Patients receive 2D image review using standard computer screen on study. Patients undergo MRI and CT imaging at screening and on study
Magnetic Resonance Imaging
Undergo MRI
Computed Tomography
Undergo CT
Best Practice
Review imaging on standard computer screen
Questionnaire Administration
Complete questionnaire
Cohort II (virtual reality)
Patients receive image review using virtual reality stimulation on study. Patients also view MRI treatment room using virtual reality stimulation. Patients undergo MRI and CT imaging at screening and on study
Magnetic Resonance Imaging
Undergo MRI
Computed Tomography
Undergo CT
Virtual Technology Intervention
Review virtual reality images
Questionnaire Administration
Complete questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magnetic Resonance Imaging
Undergo MRI
Computed Tomography
Undergo CT
Best Practice
Review imaging on standard computer screen
Questionnaire Administration
Complete questionnaire
Magnetic Resonance Imaging
Undergo MRI
Computed Tomography
Undergo CT
Virtual Technology Intervention
Review virtual reality images
Questionnaire Administration
Complete questionnaire
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants must be histologically proven neoplasm
* Planned to undergo radiation treatment using the MR Linac
Exclusion Criteria
* Non-English speaking patients
* Pediatric patients are ineligible
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Thomas Jefferson University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adam Mueller, MD
Role: PRINCIPAL_INVESTIGATOR
Thomas Jefferson University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JT 20764
Identifier Type: OTHER
Identifier Source: secondary_id
22C.714
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.